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Response to Liu et al.
To the Editor: The ﬁndings of Liu and colleagues seem to
contradict our recent ﬁndings of an association of primary
open-angle glaucoma (MIM 137760) with rare NTF4 (MIM
162662) variants, one of which was shown to reduce TRKB
signaling in vitro.1 The authors have now investigated
a similar patient group with comparable phenotypic char-
acteristics and indeed also found rare NTF4 variants in this
group. Interestingly, they found an even higher number of
variants in the control group (12/533). This is in marked
contrast to our ﬁndings because we found only 1 variant
in 895 control individuals. This difference is statistically
signiﬁcant (p< 0.001, c2 test). We noticed that the control
group use by Liu and coworkers is signiﬁcantly younger
than ours (64.7 5 14.2 years versus 73.9 5 6.4 years).
Also, the control group seems to be a hospital-derived
control group, similar to our ﬁrst control group. Although
they have the advantage of being ophthalmologically
investigated to exclude any sign of glaucoma, such control
groups have the inherent potential for undetected bias
because probands were identiﬁed when they sought
ophthalmological care. Our second control group was pop-
ulation based, which should be free of this bias, although
we expect this group to contain undiagnosed or unrecog-
nized patients at the population frequency of glaucoma.
Nevertheless, this is unlikely given the average age of
75.5 5 7.4 years in this subgroup.
We cannot exclude, though, that some of the variants
identiﬁed either in the original study or in this one are
benign variants; we showed a functional impairment
only for R206W. This situation is similar to that of the asso-
ciation of rare variants in CYP1B1 (MIM 601771) and
primary open-angle glaucoma. Only when variants were
systematically classiﬁed as either benign or functionally
impairing did a signiﬁcant association become evident.2
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AJHG 579_5studies fail to replicate a true association ﬁnding, especially
when the study involves rare variants, probably because of
sampling effects. It may also be possible that the magni-
tude of effect in our study was overestimated as a result
of such an effect. Finally, only a meta-analysis of different
studies in glaucoma patients as well as population-based
control individuals will eventually clarify the role of
NTF4 in glaucoma.
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